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Kathryn B. Garber1,*X Chromosome Inactivation at Single-Cell Resolution
X chromosome inactivation (XCI) in females is random, or
is it? The selection of the X to be inactivated is set early in
the embryo and, as far as we know, is a chance event over-
all. Particularly because XCI occurs so early in embryogen-
esis, the initial random selection of the X to be inactivated
does not necessarily translate into complete randomness
throughout the body. Different tissues arise from different
embryonic layers, after all, and certain cell types have very
specific migration and differentiation processes that will
govern their location relative to the cells from which
they originate. To understand XCI patterns at a resolution
previously unachieved, a group led by Jeremy Nathans in-
serted a different fluorescent reporter into each copy of the
X-linked gene Hprt, creating heterozygous female mice
with red cells in which one X was active and green cells
in which the other X was active. The striking images in
this paper illustrate the variability in XCI patterns that
can be found within siblings and between tissues, and
they also show examples of left-right asymmetry for XCI
within an individual. The two-color system allowed the
authors to sort cells on the basis of the active X in order
to measure gene expression from the inactive X. They
also explored XCI in the content of an X-linked mutation
to determine how XCI patterns influence phenotypic
expression at a local level.
Wu et al. (2014). Neuron 81, 103–119.
Alpha-1 Antitrypsin Regulates TNF-a Signaling
Although apparently quite underdiagnosed, a-1 anti-
trypsin deficiency (AATD) is a significant contributor to
chronic obstructive pulmonary disease and is one of the
most common single-gene disorders. AAT is a natural in-
hibitor of several serine proteases, and it is believed that
when it is deficient, the relative excess of these proteases
leads to lung damage. New data from Bergin et al. suggest
that inflammation might also contribute to the pathogen-
esis of AATD in ways that were not previously appreciated.
They discovered that AAT regulates proinflammatory tu-
mor necrosis factor a (TNF-a) and downstream neutrophil
signaling. In AATD patients, increased activation of the
TNF-a system yields a release of granule proteins from
neutrophils and an increased incidence of autoantibodies
to one of these granule proteins, lactoferrin. Intravenous
augmentation therapy with purified human AAT has
been used to treat AATD with the idea that it will bring1Department of Human Genetics, Emory University School of Medicine, Atlan
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tially slow the progression of lung disease. Bergin et al.
also show that this treatment is associated with decreases
in TNF-a signaling and in the levels of the lactoferrin auto-
antibodies. This new view of AATD pathogenesis might
also have implications for other diseases that involve
TNF-a misregulation.
Bergin et al. (2014). Sci. Transl. Med. 6, 217ra1.
Releasing the Ring
Human cells don’t do well with circularized chromo-
somes, which are known as ring chromosomes. Picture
the alignment of X-shaped chromosomes attached to
spindle fibers—the distorted shape of a ring chromo-
some makes it difficult for the chromosome to proceed
through these normal meiotic and mitotic processes,
leaving them unstable. The typical result of this insta-
bility is an aneuploid cell. To better understand ring-
chromosome instability, Bershteyn et al. tried to generate
induced pluripotent stem cells from fibroblasts con-
taining a ring chromosome 17. The majority of cells in
the resulting successful clones had 46 chromosomes,
including two copies of chromosome 17, but lacked the
ring 17. Did the ring open up, yielding a linear structure,
or was there something else going on? SNP microarrays
revealed homozygosity across chromosome 17, thereby
clarifying the mechanism: when the ring was lost, a
compensatory duplication of the other chromosome 17
led to uniparental disomy, normalizing the gene dosage
across the chromosome. A similar result was observed
when they started with a ring chromosome 13, so it is
not unique to chromosome 17 and might be a useful
tool for understanding the regulation of chromosome
number.
Bershteyn et al. (2014). Nature. Published online January 12,
2014. http://dx.doi.org/10.1038/nature12923.
Factors Associated with the Outcome of 22q11.2
Deletion Syndrome
Although not unique to the syndrome, 22q11.2 deletion
is one of the recurrent pathogenic copy-number variants
with reduced penetrance and variable expression. One
such variable feature is intellectual ability; although
many people with 22q11.2 deletion syndrome have
a learning disability, only about 10% have moderate to
severe intellectual disability. Considering that 85% ofta, GA 30322, USA
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patients have a nearly identical deletion, the size of the
deletion is not the key to this variable expression. Look-
ing for alternative explanations, Cheung et al. explored
whether clinical features might be correlated with intellec-
tual disability in a group of adults with 22q11.2 deletion
syndrome. Logistic regressions uncovered neonatal hypo-
calcemia as a predictor of intellectual disability. This link
seems to occur because hypocalcemia causes neonatal sei-
zures, which themselves can lead to long-term neurodeve-
lopmental issues. Currently, the hypocalcemia in 22q11.2
deletion syndrome is generally considered self-resolving;
the link with intellectual disability led the authors to argue
for early recognition and management of the hypocalce-
mia as a potential way to reduce the likelihood of severe
intellectual disability in people with 22q11.2 deletion
syndrome.
Cheung et al. (2014). Genet. Med. 160, 40-44.160 The American Journal of Human Genetics 94, 159–160, FebruaryMeta-analysis of Rare Variants
Meta-analyses of common genetic variation generated
some of the major success stories from genome-wide asso-
ciation studies. As researchers begin to seek rare genetic
variation that might also contribute to complex traits,
new approaches are needed so that data from multiple
studies can be combined easily, particularly given the
massive sample sizes that will be needed for finding these
associations. Gonc¸alo Abecasis and colleagues have devel-
oped a freely available and flexible method of identifying
rare-variant associations. With a real data set of more
than 18,000 individuals, they sought rare-variant associa-
tions with blood lipid levels as a quantitative trait and
show that their method is powerful and can detect associ-
ations with many previously identified loci.
Liu et al. (2013). Nat. Genet. Published online December 15,
2013. http://dx.doi.org/10.1038/ng.2852.This month in Our Sister JournalsPersonalized Gene Expression
Both genetic and nongenetic factors are likely to influence
the expression level of individual genes. To identify these
factors, many have used the average expression level of a
gene as the phenotype of interest. Wang et al. looked at
this problem a little bit differently. They wanted to find
expression loci that influence the variance of gene expres-
sion in a population. They found them by using gene
expression data from a twin cohort, which provided anice immediate way of validating their results with data
from the matched twin. The sample also allowed them to
disentangle the genetic and environmental effects that
contribute to the expression differences. Considering
gene expression as a complex trait, this provides a nice
model for thinking about the ways in which multiple
inputs combine to influence one phenotypic variable.
Wang et al. (2013). Genetics. Published online December 2,
2013. http://dx.doi.org/10.1534/genetics.113.157503.6, 2014
